Lowest adjusted risk of switching and highest intensification risk for patients prescribed sufonylureas Most patients with type 2 diabetes initiating antidiabetic medication (ADM) experience treatment modification within one year, according to a study published in the December issue of the American Journal of Managed Care. David T. Liss, Ph.D., from the Northwestern University Feinberg School of...